Development and Evaluation of a Therapeutic Education Intervention in Prostate Cancer Patients Treated With Radical Prostatectomy to Improve Their Sexuality
- Conditions
- Prostate Cancer
- Registration Number
- NCT03572621
- Lead Sponsor
- Hospices Civils de Lyon
- Brief Summary
Prostate cancer is the most common cancer in France (54,000 cases in 2011). About 20,000 radical prostatectomies (PR) per year are performed. Despite the progress of PR over the past 20 years, the rate of erectile dysfunction post PR varies between 30 and 90% and only 16% of operated men recover their pre-treatment erections.
There is currently no validated post-prostatectomy rehabilitation protocol. The associations of patients, including the National Association of Prostate Cancer Patients have a very strong demand for treatment of sexual problems after treatment.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 240
Patients treated in urology consultation at the University Hospital of Lyon Sud or Edouard Herriot:
- Aged over 18
- presenting a cancerous pathology of the prostate having an indication of radical prostatectomy with or without preservation of the neurovascular strips.
- affiliated to a social security scheme.
- and having been informed and given informed consent to participation in the program.
- Refusal of participation, signature of consent,
- protected major patients, under guardianship or curators.
- Patients unable to understand the course of the study
- Patient with a documented history of cognitive or psychiatric disorders.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Change the quality of sexual life of patients treated with radical prostatectomy (PR) 18 months Comparison of the difference in self-Esteem quotation and Relationship (SEAR) questionnaire, between the experimental group and control, between inclusion and Month 18.
- Secondary Outcome Measures
Name Time Method Sexual function Month 1, 6, 12 and 18 Measure of The International Index of Erectile Function (IIEF-EF) score. This validated score measures the erectile component.
Penis size (cm) Month 1, 6, 12 and 18 Knowledge acquisition measured by quizz build for the study made of simulated cases Month 1, 6, 12 and 18 Anxiety level measured by the Hospital Anxiety and Depression (HAD) scale Month 6 and18 Sexual quality of life of the partner Month 1, 6, 12 and 18 Index of Sexual Life (ISL) questionnaire, validated questionnaire specifically created to assess the impact of erectile dysfunction (ED) in the partner.
Depression level measured by the Hospital Anxiety and Depression (HAD) scale Month 6 and18 General quality of life Month 1, 6, 12 and 18 Signing of questionnaire EuroQol-D5 (EQ-D5)
Number of erections obtained in the last month Month 1, 6, 12 and 18 Patient questionnaire to be filled every month at home by the patient and the partner
Erection Hardness Score (EHS) Month 1, 6, 12 and 18 Continence: urinary handicap measurement scale (MHU) Month 1, 6, 12 and 18 Number of intracavernous injections performed per week Month18 Patient questionnaire to be filled every month at home by the patient and the partner
acquisition of sexual intercourse management skills measured by quizz build for the study made of simulated cases Month 1, 6, 12 and 18 Number of reports deemed satisfactory Month 1, 6, 12 and 18 Patient questionnaire to be filled every month at home by the patient and the partner
Patient Activation Measure (questionnaire PAM) Month18
Trial Locations
- Locations (2)
Hôpital Hédouard Herriot
🇫🇷Lyon, France
Centre Hospitalier Lyon Sud
🇫🇷Pierre-Bénite, France
Hôpital Hédouard Herriot🇫🇷Lyon, FranceCUZIN Béatrice, MDContactBéatrice CUZIN, MDPrincipal InvestigatorMarc COLOMBEL, MDSub InvestigatorLionel BADET, MDSub InvestigatorSébastien CROUZET, MDSub InvestigatorRicardo CODAS DUARTE, MDSub InvestigatorEmilien SEIZILLES DE MAZANCOURT, MDSub InvestigatorXavier MATILLON, MDSub InvestigatorHakim FASSI-FEHRI, MDSub InvestigatorHaixia YE, MDSub InvestigatorSaid OURFALI, MDSub Investigator